OBJECTIVE: To evaluate markers of in vivo platelet function (urinary 11-dehydro-thromboxane B(2) [11-dehydroTXB(2)] and 2,3-dinorTXB(2)) and assess their response to administration of 2 commonly used dosages of aspirin in healthy dogs. ANIMALS: 20 healthy dogs. PROCEDURES: Urine was collected prior to aspirin administration and on the morning following the last evening administration. Twenty dogs received aspirin (1 mg/kg, PO, q 24 h) for 7 consecutive doses. After a washout period of 5 months, 10 dogs received a single dose of aspirin (10 mg/kg, PO). Concentrations of urinary thromboxane metabolites 11-dehydroTXB(2) and 2,3-dinorTXB(2) were measured via ELISA, and values were normalized to urine creatinine concentration. RESULTS: Median baseline 11-dehydroTXB(2) concentrations were 0.38 ng/mg of creatinine (range, 0.15 to 1.13 ng/mg). Mean ± SD baseline 2 at a 3-dinorTXB(2) concentrations were 6.75 ± 2.77 ng/mg of creatinine. Administration of aspirin at a dosage of 1 mg/kg, PO, every 24 hours for 7 days did not significantly decrease urinary 11-dehydroTXB(2) concentration, but administration of the single aspirin dose of 10 mg/kg did significantly decrease 11-dehydroTXB(2) concentration by a median of 45.5% (range, 28.2% to 671%). Administration of the 1 mg/kg aspirin dosage significantly decreased urinary 2,3-dinorTXB(2) concentration by a mean ± SD of 33.0 ± 23.7%. Administration of the single aspirin dose of 10 mg/kg also significantly decreased 2,3-dinorTXB(2) concentration by a mean ± SD of 46.7 ± 12.6%. CONCLUSIONS AND CLINICAL RELEVANCE: Aspirin administration (1 mg/kg/d) may be insufficient for reliable platelet inhibition in healthy dogs.
OBJECTIVE: To evaluate markers of in vivo platelet function (urinary 11-dehydro-thromboxane B(2) [11-dehydroTXB(2)] and 2,3-dinorTXB(2)) and assess their response to administration of 2 commonly used dosages of aspirin in healthy dogs. ANIMALS: 20 healthy dogs. PROCEDURES: Urine was collected prior to aspirin administration and on the morning following the last evening administration. Twenty dogs received aspirin (1 mg/kg, PO, q 24 h) for 7 consecutive doses. After a washout period of 5 months, 10 dogs received a single dose of aspirin (10 mg/kg, PO). Concentrations of urinary thromboxane metabolites 11-dehydroTXB(2) and 2,3-dinorTXB(2) were measured via ELISA, and values were normalized to urine creatinine concentration. RESULTS: Median baseline 11-dehydroTXB(2) concentrations were 0.38 ng/mg of creatinine (range, 0.15 to 1.13 ng/mg). Mean ± SD baseline 2 at a 3-dinorTXB(2) concentrations were 6.75 ± 2.77 ng/mg of creatinine. Administration of aspirin at a dosage of 1 mg/kg, PO, every 24 hours for 7 days did not significantly decrease urinary 11-dehydroTXB(2) concentration, but administration of the single aspirin dose of 10 mg/kg did significantly decrease 11-dehydroTXB(2) concentration by a median of 45.5% (range, 28.2% to 671%). Administration of the 1 mg/kg aspirin dosage significantly decreased urinary 2,3-dinorTXB(2) concentration by a mean ± SD of 33.0 ± 23.7%. Administration of the single aspirin dose of 10 mg/kg also significantly decreased 2,3-dinorTXB(2) concentration by a mean ± SD of 46.7 ± 12.6%. CONCLUSIONS AND CLINICAL RELEVANCE: Aspirin administration (1 mg/kg/d) may be insufficient for reliable platelet inhibition in healthy dogs.
Authors: A Dudley; J Thomason; S Fritz; J Grady; J Stokes; R Wills; L Pinchuk; A Mackin; K Lunsford Journal: J Vet Intern Med Date: 2012-12-26 Impact factor: 3.333
Authors: James W Swann; Oliver A Garden; Claire L Fellman; Barbara Glanemann; Robert Goggs; Dana N LeVine; Andrew J Mackin; Nathaniel T Whitley Journal: J Vet Intern Med Date: 2019-03-07 Impact factor: 3.333